Guanhao Biotech Co.,Ltd. entered into a share subscription agreement for the placement of not more than 55,803,571 A shares at an issue price of CNY 8.96 per share for gross proceeds of not more than CNY 500,000,000 on March 22, 2023. The transaction will include participation from Beijing Century Tianfu Venture Capital Center (Limited Partnership), Beijing Tianyou Investment Co., Ltd. and Jiangsu Tianyou Jingan Investment Co., Ltd. The shares issued shall not be transferred within 36 months from the date of completion of this issuance. The transaction has been approved at the 15th meeting of the company's fifth board of directors and still needs to be reviewed and approved by the company's shareholders' meeting, Shenzhen Stock Exchange and China Securities Regulatory Commission.